Should self-administered voluntary assisted dying be supervised? A Queensland case

IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Eliana Close, Katrine Del Villar, Ben P White
{"title":"Should self-administered voluntary assisted dying be supervised? A Queensland case","authors":"Eliana Close,&nbsp;Katrine Del Villar,&nbsp;Ben P White","doi":"10.5694/mja2.52634","DOIUrl":null,"url":null,"abstract":"<p>All Australian states and the Australian Capital Territory have voluntary assisted dying (VAD) laws. Medication management will be topical in these laws’ mandatory reviews following a Queensland coronial inquest into the death of a person who consumed a VAD substance prescribed for their spouse. In a decision issued on 11 September 2024, the coroner found “operational flaws” in Queensland's VAD law, declaring current self-administration procedures “inadequate to provide for medication safety and to prevent deliberate misuse”.<span><sup>1</sup></span> These findings have nationwide relevance as all Australian VAD laws permit eligible persons to self-administer without a health practitioner present.<span><sup>2</sup></span></p><p>On 16 May 2023, ABC (pseudonym), an older person, died after purposely consuming a VAD substance prescribed for their terminally ill spouse.<span><sup>1</sup></span> Due to the sensitive nature of the case, the coroner's report includes a ban on publishing identifying details. Accordingly, ABC, their spouse (the terminally ill patient), and adult child are referred to using neutral terms.</p><p>The circumstances leading to ABC's death are set out in Box 1.</p><p>The coroner recommended that self-administration should be supervised by a health practitioner, an option that was considered by the Queensland Law Reform Commission (prompted by a proposed VAD bill)<span><sup>4</sup></span> but was not adopted.<span><sup>5</sup></span></p><p>The coroner warned of “[f]urther calamity and heartbreak” for patients and families without system reform.<span><sup>1</sup></span> He specifically confined his critical remarks to the system rather than the individuals working within it, noting that QVAD-SPS personnel had not breached the law or any protocol.</p><p>The Australian model of VAD is characterised by narrow eligibility criteria and numerous safeguards.<span><sup>2</sup></span> One of these safeguards is that only medical practitioners (and in some states, nurses or nurse practitioners) who complete mandatory training and meet additional experience and expertise requirements can participate in key aspects of VAD (“VAD practitioners”). Two independent VAD practitioners assess whether a person is eligible for VAD (in the states, only medical practitioners can do VAD assessments; but in the ACT, one practitioner can be a nurse practitioner). If the person is eligible, the lead VAD practitioner (“coordinating practitioner”) writes the prescription for the VAD substance.</p><p>Australian VAD medication protocols are not publicly available but, as in other countries, the VAD substance is a combination of medications used in health care settings (including a Schedule 8 [S8] medicine).<span><sup>3, 6</sup></span> The medication protocol differs depending on the method of administration. Self-administration involves mixing a liquid that a person drinks (or ingests via nasogastric tube), while practitioner administration typically involves intravenous injection.<span><sup>6</sup></span></p><p>Victoria and South Australia require self-administration unless the person cannot swallow or digest the substance.<span><sup>2</sup></span> Other jurisdictions allow more choice and have much higher rates of practitioner administration (Box 2).<span><sup>2, 7</sup></span> No Australian VAD laws require supervised self-administration, although Tasmania's law has this as an option.<span><sup>2</sup></span></p><p>Nationally, there were 2467 VAD deaths since 2019; 1258 (51%) involved self-administration.<span><sup>7</sup></span> More eligible people were issued the VAD substance for self-administration but chose not to take it.<span><sup>7</sup></span> The ABC case is the sole instance of a person taking a VAD substance not prescribed for them.</p><p>Compliance with legal requirements to return the VAD substance has been high. To date, 17 cases involved a delay in returning the VAD substance: 12 from Victoria (between 2019 and 2024);<span><sup>7, 8</sup></span> four from Western Australia (between 2021 and 2023);<span><sup>7</sup></span> and one from Queensland (the ABC case).<span><sup>1</sup></span></p><p>In the ABC case, the coroner heard evidence of reports of complications after self-administration, including vomiting and an extended period to death.<span><sup>1</sup></span> Data on VAD complication rates is limited.<span><sup>7</sup></span> In its 2022–2023 annual report, Victoria's VAD Review Board stated that it had reviewed self-administration cases with a prolonged time to death, primarily involving persons with neurodegenerative diseases causing autonomic system failure.<span><sup>9</sup></span> There are no reports of the VAD substance not causing death.</p><p>Whether to require self-administration of VAD to be supervised is a policy choice informed by weighing evidence and competing values.<span><sup>14</sup></span> A policy position that prioritises community safety and emphasises protecting human life would support the coroner's view that the system's goal must be “precisely 100% compliance and that no innocent, nor unintended, person is in any way harmed”.<span><sup>1</sup></span> With this view, constraints on patient autonomy to choose the timing of one's death, delays, the likelihood that some patients will be unable to access VAD, and increased burdens on practitioners, are necessary corollaries of prioritising patient and community safety and avoiding the risk of death by unlawful use of a VAD substance.</p><p>Alternatively, a policy position that takes a more pragmatic lens aims to balance safety with the burdens of supervised self-administration and accepts that adverse outcomes sometimes occur in health care. This position accepts the relatively remote risks of permitting private self-administration. As the Australian Medical Association Queensland stated, “a one-off event or death did not necessarily mean the laws were terrible or needed fundamental reform”.<span><sup>15</sup></span> This position is also informed by impacts on the system and individual practitioners. Occasional adverse outcomes are an unavoidable consequence of having a VAD system that prioritises patient choice and access and considers the broader impacts of supervised self-administration on the VAD system and workforce. This policy position focuses on measures to mitigate risks, rather than eliminating them completely.</p><p>Whatever policy option is chosen, the government must ensure that it is adequately resourced. Experience with health care systems generally has shown that under-resourced systems with a poorly supported workforce can fail to deliver safe and high quality care. Hence, if supervised self-administration is preferred on the grounds of patient and community safety, there is a duty to provide any additional resourcing required. We urge governments to closely consider the ABC case in their VAD reviews and offer several recommendations for consideration (Box 3).</p><p>Open access publishing facilitated by Queensland University of Technology, as part of the Wiley – Queensland University of Technology agreement via the Council of Australian University Librarians.</p><p>Ben White has been engaged (with colleagues) by the Victorian, Western Australian and Queensland governments to design and provide the legislatively mandated training for health practitioners involved in voluntary assisted dying in those states. Eliana Close and Katrine Del Villar were employed on these projects. Ben White has also received funding from state governments for voluntary assisted dying research. In addition, he (with a colleague) developed a model bill for voluntary assisted dying for parliaments to consider, which was discussed in the coronial case on ABC that this article examines.</p><p>Not commissioned; externally peer reviewed.</p>","PeriodicalId":18214,"journal":{"name":"Medical Journal of Australia","volume":"222 8","pages":"390-393"},"PeriodicalIF":6.7000,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.5694/mja2.52634","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Australia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.5694/mja2.52634","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

All Australian states and the Australian Capital Territory have voluntary assisted dying (VAD) laws. Medication management will be topical in these laws’ mandatory reviews following a Queensland coronial inquest into the death of a person who consumed a VAD substance prescribed for their spouse. In a decision issued on 11 September 2024, the coroner found “operational flaws” in Queensland's VAD law, declaring current self-administration procedures “inadequate to provide for medication safety and to prevent deliberate misuse”.1 These findings have nationwide relevance as all Australian VAD laws permit eligible persons to self-administer without a health practitioner present.2

On 16 May 2023, ABC (pseudonym), an older person, died after purposely consuming a VAD substance prescribed for their terminally ill spouse.1 Due to the sensitive nature of the case, the coroner's report includes a ban on publishing identifying details. Accordingly, ABC, their spouse (the terminally ill patient), and adult child are referred to using neutral terms.

The circumstances leading to ABC's death are set out in Box 1.

The coroner recommended that self-administration should be supervised by a health practitioner, an option that was considered by the Queensland Law Reform Commission (prompted by a proposed VAD bill)4 but was not adopted.5

The coroner warned of “[f]urther calamity and heartbreak” for patients and families without system reform.1 He specifically confined his critical remarks to the system rather than the individuals working within it, noting that QVAD-SPS personnel had not breached the law or any protocol.

The Australian model of VAD is characterised by narrow eligibility criteria and numerous safeguards.2 One of these safeguards is that only medical practitioners (and in some states, nurses or nurse practitioners) who complete mandatory training and meet additional experience and expertise requirements can participate in key aspects of VAD (“VAD practitioners”). Two independent VAD practitioners assess whether a person is eligible for VAD (in the states, only medical practitioners can do VAD assessments; but in the ACT, one practitioner can be a nurse practitioner). If the person is eligible, the lead VAD practitioner (“coordinating practitioner”) writes the prescription for the VAD substance.

Australian VAD medication protocols are not publicly available but, as in other countries, the VAD substance is a combination of medications used in health care settings (including a Schedule 8 [S8] medicine).3, 6 The medication protocol differs depending on the method of administration. Self-administration involves mixing a liquid that a person drinks (or ingests via nasogastric tube), while practitioner administration typically involves intravenous injection.6

Victoria and South Australia require self-administration unless the person cannot swallow or digest the substance.2 Other jurisdictions allow more choice and have much higher rates of practitioner administration (Box 2).2, 7 No Australian VAD laws require supervised self-administration, although Tasmania's law has this as an option.2

Nationally, there were 2467 VAD deaths since 2019; 1258 (51%) involved self-administration.7 More eligible people were issued the VAD substance for self-administration but chose not to take it.7 The ABC case is the sole instance of a person taking a VAD substance not prescribed for them.

Compliance with legal requirements to return the VAD substance has been high. To date, 17 cases involved a delay in returning the VAD substance: 12 from Victoria (between 2019 and 2024);7, 8 four from Western Australia (between 2021 and 2023);7 and one from Queensland (the ABC case).1

In the ABC case, the coroner heard evidence of reports of complications after self-administration, including vomiting and an extended period to death.1 Data on VAD complication rates is limited.7 In its 2022–2023 annual report, Victoria's VAD Review Board stated that it had reviewed self-administration cases with a prolonged time to death, primarily involving persons with neurodegenerative diseases causing autonomic system failure.9 There are no reports of the VAD substance not causing death.

Whether to require self-administration of VAD to be supervised is a policy choice informed by weighing evidence and competing values.14 A policy position that prioritises community safety and emphasises protecting human life would support the coroner's view that the system's goal must be “precisely 100% compliance and that no innocent, nor unintended, person is in any way harmed”.1 With this view, constraints on patient autonomy to choose the timing of one's death, delays, the likelihood that some patients will be unable to access VAD, and increased burdens on practitioners, are necessary corollaries of prioritising patient and community safety and avoiding the risk of death by unlawful use of a VAD substance.

Alternatively, a policy position that takes a more pragmatic lens aims to balance safety with the burdens of supervised self-administration and accepts that adverse outcomes sometimes occur in health care. This position accepts the relatively remote risks of permitting private self-administration. As the Australian Medical Association Queensland stated, “a one-off event or death did not necessarily mean the laws were terrible or needed fundamental reform”.15 This position is also informed by impacts on the system and individual practitioners. Occasional adverse outcomes are an unavoidable consequence of having a VAD system that prioritises patient choice and access and considers the broader impacts of supervised self-administration on the VAD system and workforce. This policy position focuses on measures to mitigate risks, rather than eliminating them completely.

Whatever policy option is chosen, the government must ensure that it is adequately resourced. Experience with health care systems generally has shown that under-resourced systems with a poorly supported workforce can fail to deliver safe and high quality care. Hence, if supervised self-administration is preferred on the grounds of patient and community safety, there is a duty to provide any additional resourcing required. We urge governments to closely consider the ABC case in their VAD reviews and offer several recommendations for consideration (Box 3).

Open access publishing facilitated by Queensland University of Technology, as part of the Wiley – Queensland University of Technology agreement via the Council of Australian University Librarians.

Ben White has been engaged (with colleagues) by the Victorian, Western Australian and Queensland governments to design and provide the legislatively mandated training for health practitioners involved in voluntary assisted dying in those states. Eliana Close and Katrine Del Villar were employed on these projects. Ben White has also received funding from state governments for voluntary assisted dying research. In addition, he (with a colleague) developed a model bill for voluntary assisted dying for parliaments to consider, which was discussed in the coronial case on ABC that this article examines.

Not commissioned; externally peer reviewed.

Abstract Image

应该监督自我管理的自愿协助死亡吗?昆士兰的一个案例
澳大利亚所有州和首都地区都有自愿协助死亡(VAD)法律。药物管理将成为这些法律强制性审查的主题,此前昆士兰州对一名服用了为其配偶规定的VAD物质的人的死亡进行了验尸调查。在2024年9月11日发布的一项决定中,验尸官发现昆士兰州的VAD法律存在“操作缺陷”,宣布目前的自我管理程序“不足以提供药物安全和防止故意滥用”这些发现具有全国性的相关性,因为所有澳大利亚VAD法律都允许符合条件的人在没有保健医生在场的情况下进行自我管理。2023年5月16日,ABC(化名),一名老年人,在故意服用为其身患绝症的配偶开的VAD物质后死亡由于案件的敏感性,验尸官的报告禁止公布身份细节。因此,ABC,他们的配偶(绝症患者)和成年子女被称为中性术语。导致ABC死亡的情况列于方框1。验尸官建议,自我用药应由一名保健医生监督,昆士兰州法律改革委员会考虑了这一选择(受到拟议的VAD法案的推动)4,但未被采纳。验尸官警告说,如果不进行体制改革,病人和家属将面临“进一步的灾难和心碎”他特别将批评的言论局限于该系统,而不是在该系统内工作的个人,并指出,QVAD-SPS人员没有违反法律或任何议定书。澳大利亚VAD模式的特点是资格标准狭窄,保障措施众多其中一项保障措施是,只有完成强制性培训并满足额外经验和专业知识要求的医疗从业人员(在某些州是护士或执业护士)才能参加VAD的关键方面(“ VAD从业人员”)。两名独立的VAD医生评估一个人是否有资格获得VAD(在美国,只有医生可以进行VAD评估;但在ACT考试中,一名执业者可以是执业护士)。如果患者符合条件,VAD主治医师(“协调医师”)会为VAD药物开处方。澳大利亚VAD药物方案尚未公开,但与其他国家一样,VAD物质是卫生保健机构使用的药物组合(包括附表8 [S8]药物)。3,6用药方案因给药方法而异。自我给药包括混合一种液体,一个人喝(或通过鼻胃管摄入),而医生给药通常包括静脉注射。维多利亚州和南澳大利亚州要求自行用药,除非患者不能吞咽或消化该物质其他司法管辖区允许更多选择,从业人员管理率也高得多(框2)。2,7澳大利亚的VAD法律不要求有监督的自我管理,尽管塔斯马尼亚州的法律有这一选项。2 .自2019年以来,全国共有2467例VAD死亡;1258例(51%)涉及自我管理更多符合条件的人被发给VAD物质用于自我给药,但选择不服用它ABC病例是一个人服用非处方VAD物质的唯一实例。退还VAD物质符合法律要求的情况一直很高。迄今为止,有17起案件涉及延迟归还VAD物质:12起来自维多利亚州(2019年至2024年);7,8起来自西澳大利亚州(2021年至2023年);7起来自昆士兰州(ABC案件)。在ABC的案例中,验尸官听到了自我给药后出现并发症的报告,包括呕吐和长时间死亡VAD并发症发生率的数据是有限的维多利亚州VAD审查委员会在其2022-2023年年度报告中指出,它审查了自我给药导致死亡时间延长的病例,主要涉及神经退行性疾病患者,导致自主系统衰竭没有关于VAD物质不会导致死亡的报告。是否要求对VAD的自我管理进行监督是一个权衡证据和竞争价值的政策选择优先考虑社区安全并强调保护人类生命的政策立场将支持验尸官的观点,即该系统的目标必须“精确地100%遵守,并且没有无辜的,也没有意外的人受到任何方式的伤害”根据这一观点,对患者自主选择死亡时间的限制、延迟、一些患者无法获得VAD的可能性以及从业人员负担的增加,是优先考虑患者和社区安全以及避免非法使用VAD物质造成死亡风险的必然结果。 另一种选择是,采取更务实的政策立场,旨在平衡安全与受监督的自我管理的负担,并接受医疗保健有时会出现不良后果。这一立场接受允许私人自我管理的相对较小的风险。正如昆士兰澳大利亚医学协会所说,“一次性事件或死亡并不一定意味着法律可怕或需要根本改革”这个位置也被告知对系统和个人从业人员的影响。VAD系统优先考虑患者的选择和获取,并考虑监督自我管理对VAD系统和工作人员的更广泛影响,因此偶尔出现的不良后果是不可避免的。这一政策立场侧重于减轻风险的措施,而不是完全消除风险。无论选择何种政策,政府都必须确保资源充足。卫生保健系统的经验一般表明,资源不足的系统加上得不到支持的工作人员可能无法提供安全和高质量的卫生保健。因此,如果出于患者和社区安全的考虑,更倾向于有监督的自我管理,则有责任提供所需的任何额外资源。我们敦促各国政府在其VAD审查中密切考虑ABC案例,并提出若干建议供审议(方框3)。开放获取出版由昆士兰科技大学促进,作为澳大利亚大学图书馆员理事会Wiley -昆士兰科技大学协议的一部分。本·怀特(和他的同事们)与维多利亚州、西澳大利亚州和昆士兰州政府合作,为这些州参与自愿协助死亡的卫生从业人员设计并提供法律强制培训。Eliana Close和Katrine Del Villar受雇于这些项目。本·怀特还从州政府获得了自愿协助死亡研究的资金。此外,他(与一位同事)制定了一项自愿协助死亡的示范法案,供议会考虑,这在本文研究的ABC coronial案件中进行了讨论。不是委托;外部同行评审。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Journal of Australia
Medical Journal of Australia 医学-医学:内科
CiteScore
9.40
自引率
5.30%
发文量
410
审稿时长
3-8 weeks
期刊介绍: The Medical Journal of Australia (MJA) stands as Australia's foremost general medical journal, leading the dissemination of high-quality research and commentary to shape health policy and influence medical practices within the country. Under the leadership of Professor Virginia Barbour, the expert editorial team at MJA is dedicated to providing authors with a constructive and collaborative peer-review and publication process. Established in 1914, the MJA has evolved into a modern journal that upholds its founding values, maintaining a commitment to supporting the medical profession by delivering high-quality and pertinent information essential to medical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信